The expression of SLA-DR was the lowest on the CD14+CD163− monocytes and it did not change significantly during endotoxemia regardless of the iNO + hydrocortisone treatment (Figure 3A). This evidence concerns the gene CD163 and serum lipopolysaccharide activity.